Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep783 | Reproductive and Developmental Endocrinology | ECE2020

Establishing an anti-müllerian hormone (AMH) cut-off to determine polycystic ovarian morphology (PCOM) supporting diagnosis of polycystic ovarian syndrome (PCOS): The APHRODITE study

Dietz de Loos Alexandra , Hund Martin , Buck Katharina , Meun Cindy , Sillman Johanna , Laven Joop

PCOS is a common pathology in women of reproductive age, and ~70% of affected women remain undiagnosed. Clinical features of PCOS include ovulatory dysfunction, hyperandrogenism and PCOM (Rotterdam criteria). Replacement of transvaginal ultrasound (TVUS) with a blood test for PCOM is clinically desirable, as lack of access to TVUS may contribute to underdiagnosis of PCOS. We aimed to derive and validate a cut-off for AMH to discriminate PCOM using the Elecsys AMH Plus imm...

ea0070oc9.3 | Reproductive and Developmental Endocrinology | ECE2020

Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients

Moolhuijsen Loes , Louwers Yvonne V , Meun Cindy , Broer Linda , Uitterlinden Andre G , Sisk Ryan K , Dunaif Andrea , Laven Joop SE , Visser Jenny A

Introduction: Polycystic ovary syndrome (PCOS), the most common endocrine disorder in women of reproductive age, is diagnosed based on three criteria, including a polycystic ovarian morphology. Moreover, women with PCOS have elevated serum Anti-Müllerian Hormone (AMH) levels, a hormone known to correlate with follicle number. In addition, AMH production per follicle is suggested to be higher in PCOS. Little is known about AMH gene regulation. Hence, this study aims to inv...